Jeffrey S. Finman, Ph. D.

Jeffrey S. Finman, Ph. D.

Chief of Biostatistics

Dr. Finman has over 35 years of drug development experience in the areas of clinical trial design, conduct, reporting, oversight and in defense of regulatory submissions. Prior to being named as Chief of Biostatistics for Cognitive Research Corporation, Dr. Finman spent 24 years in roles of increasing responsibility at Pfizer, Inc., where he had oversight of clinical statistics, statistical programming, data management, and biometrics project managers and led statistical support for numerous NDA submissions including in-licensed and co-development submissions. He founded Jupiter Point Pharma Consulting, LLC in 2009 and continues to provide technical statistical support for sponsor organizations in the planning, execution and analysis of clinical studies and for development programs. He routinely provides strategic support for regulatory interactions and participates in meetings with sponsors and regulatory agencies, including sponsor representation in FDA Advisory Committee Meetings and has considerable experience serving on and in chartering Safety Review Committees and Data Safety Monitoring Boards. 


Dr. Finman’s clinical trial experience is from Phase I to Phase III and through registration across a broad range of therapeutic areas and indications, including for numerous successful NDA submissions leading to approval. As part of a long-standing collaboration with CRC (prior to his role as Chief of Biostatistics), Dr. Finman also has particular expertise in the design and analysis of driving studies using CRC’s customized driving simulator.


Dr. Finman is also a Board Member of Sofia Sees Hope, a nonprofit 501(c)3 patient advocacy organization dedicated to generating awareness, raising funds for research, and providing support, education and outreach to the Leber Congenital Amaurosis and rare inherited retinal disease community.


Dr. Finman received his Ph.D. in Biostatistics from Medical College of Virginia/Virginia Commonwealth University School of Medicine and his B.S. in Statistics from the State University of New York at Oneonta.  He is a member of the American Statistical Association.


“Our deep expertise and vast experience give us the insights into the needs and requirements of our clients and industry standards.”